Eindelijk

Via solv.nl: "Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that the patent infringement proceedings before the Düsseldorf District court against CEVEC Pharmaceuticals GmbH have finally been settled." Lees hier meer.